EXTENDED RELEASE CAPSULES SUSPENSION

Brand Owner (click to sort) Address Description
CLONID-XR NextWave Pharmaceuticals Incorporated Attn: Ketan Mehta 2033 Route 130, Suite D Monmouth Junction CA 08852 Extended release capsules and suspension for oral administration of the drug clonidine, intended for the treatment of hypertension and Tourette's syndrome;
CLONITROL NextWave Pharmaceuticals Incorporated Attn: Ketan Mehta 2033 Route 130, Suite D Monmouth Junction CA 08852 Extended release capsules and suspension for oral administration of the drug clonidine, intended for the treatment of hypertension and Tourette's syndrome;
CLONIX NextWave Pharmaceuticals Incorporated Attn: Ketan Mehta 2033 Route 130, Suite D Monmouth Junction CA 08852 Extended release capsules and suspension for oral administration of the drug clonidine, intended for the treatment of hypertension and Tourette's syndrome;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A device for filling soluble containers such as capsules comprises an assembly for orienting and separating capsules including double blind capsules which have a longer cap length and shorter body length wherein such assembly has a top sheet for loading the capsules and a bottom sheet for orienting the capsules loaded therein and such said sheets capable of being relatively displaced with respect to each other. Slots are provided in the top sheet for limiting such displacement by setting free configuration for orientation of the capsules. An open closable gate is mounted to the top sheet for enabling easier loading and containment of the capsules within the top sheet, for orienting the capsules. The filler assembly has at least a pair of sheets having profile cut portions and profile-cut strip for gripping the body of the capsules especially capsules having a longer cap length and shorter body length such as double blind capsules.